Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

BACKGROUND: There is concern that selective serotonin reuptake inhibitors (SSRIs) substantially increase bleeding risk in patients taking anticoagulants. METHODS AND RESULTS: We studied 737 patients taking SSRIs in the ROCKET AF (Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Gene R., Hellkamp, Anne S., Hankey, Graeme J., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Fava, Maurizio, Fox, Keith A. A., Halperin, Jonathan L., Mahaffey, Kenneth W., Nessel, Christopher C., Patel, Manesh R., Piccini, Jonathan P., Singer, Daniel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201450/
https://www.ncbi.nlm.nih.gov/pubmed/30371223
http://dx.doi.org/10.1161/JAHA.118.008755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201450/
https://www.ncbi.nlm.nih.gov/pubmed/30371223
http://dx.doi.org/10.1161/JAHA.118.008755

Ejemplares similares